Larvol Delta - Nonclinical-Safety-and-Toxicokinetics-of-MnTE2PyP-BMX010-a-Topical-Agent-in-Phase-2-Trials-for-Psoriasis-and-Atopic-Dermatitis

BMX-010 - BioMimetix

http://www.ncbi.nlm.nih.gov/pubmed/31333066

Jul 25, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next